Baldwin demands answers on insulin price increases
Sen. Tammy Baldwin, D-Wis., wants to know why pharmaceutical companies have increased insulin prices dramatically over the last decade. Baldwin joined Democratic members of the Senate’s health committee on letters sent this week to Eli Lilly, Novo Nordisk and Sanofi. The senators noted in their letters that the cost of insulin tripled between 2002 and […]
To access this content, you must purchase a Premium membership, or log in if you are a member.
